References
- American Psychiatric Association. 2013. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders: Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington, VA: American Psychiatric Association.
- Appelbaum, Paul S., Erik Parens, Sara M. Berger, Wendy K. Chung, and Wylie Burke. 2020. “Is There a Duty to Reinterpret Genetic Data? The Ethical Dimensions.” Genetics in Medicine 22 (3): 633–639. doi:https://doi.org/10.1038/s41436-019-0679-7.
- Aronowitz, Robert A. 2001. “When Do Symptoms Become a Disease?” Annals of Internal Medicine 134: 803–808.
- Arribas-Ayllon, Michael. 2016. “After Geneticization.” Social Science & Medicine 159: 132–139. doi:https://doi.org/10.1016/j.socscimed.2016.05.011.
- Atkinson, Paul. 1981. The Clinical Experience: The Construction and Reconstruction of Medical Reality. Westmead: Gower.
- Atkinson, Paul. 1984. “Training for Certainty.” Social Science & Medicine 19 (9): 949–956. doi:https://doi.org/10.1016/0277-9536(84)90324-1.
- Babrow, Austin S., Chris R. Kasch, and Leigh A. Ford. 1998. “The Many Meanings of Uncertainty in Illness: Toward a Systematic Accounting.” Health Communication 10 (1): 1–23. doi:https://doi.org/10.1207/s15327027hc1001_1.
- Basel, Donald, and Julie McCarrier. 2017. “Ending a Diagnostic Odyssey.” Pediatric Clinics of North America 64 (1): 265–272. doi:https://doi.org/10.1016/j.pcl.2016.08.017.
- Belkadi, Aziz, Alexandre Bolze, Yuval Itan, Aurélie Cobat, Quentin B. Vincent, Alexander Antipenko, Lei Shang, Bertrand Boisson, Jean-Laurent Casanova, and Laurent Abel. 2015. “Whole-Genome Sequencing Is More Powerful Than Whole-Exome Sequencing for Detecting Exome Variants.” Proceedings of the National Academy of Sciences 112 (17): 5473–5478. doi:https://doi.org/10.1073/pnas.1418631112.
- Bertier, Gabrielle, Martin Hétu, and Yann Joly. 2016. “Unsolved Challenges of Clinical Whole-Exome Sequencing: A Systematic Literature Review of End-Users’ Views.” BMC Medical Genomics 9 (1): 52. doi:https://doi.org/10.1186/s12920-016-0213-6.
- Bertier, Gabrielle, Karine Sénécal, Pascal Borry, and Danya F. Vears. 2017. “Unsolved Challenges in Pediatric Whole-exome Sequencing: A Literature Analysis.” Critical Reviews in Clinical Laboratory Sciences 54 (2): 134–142. doi:https://doi.org/10.1080/10408363.2016.1275516.
- Bhise, Viraj, Suja S. Rajan, Dean F. Sittig, Robert O. Morgan, Pooja Chaudhary, and Hardeep Singh. 2018. “Defining and Measuring Diagnostic Uncertainty in Medicine: A Systematic Review.” Journal of General Internal Medicine 33 (1): 103–115. doi:https://doi.org/10.1007/s11606-017-4164-1.
- Biesecker, Leslie G., and Robert C. Green. 2014. “Diagnostic Clinical Genome and Exome Sequencing.” New England Journal of Medicine 370 (25): 2418–2425. doi:https://doi.org/10.1056/NEJMra1312543.
- Bland, Austin, Elizabeth A. Harrington, Kyla Dunn, Mitchel Pariani, Julia C. K. Platt, Megan E. Grove, and Colleen Caleshu. 2018. “Clinically Impactful Differences in Variant Interpretation between Clinicians and Testing Laboratories: A Single-Center Experience.” Genetics in Medicine 20 (3): 369–373. doi:https://doi.org/10.1038/gim.2017.212.
- Blaxter, Mildred. 1978. “Diagnosis as Category and Process: The Case of Alcoholism.” Social Science and Medicine 12: 9–17. doi:https://doi.org/10.1016/0271-7123.
- Borry, Pascal, Mahsa Shabani, and Heidi Carmen Howard. 2014. “Is There a Right Time to Know?: The Right Not to Know and Genetic Testing in Children.” The Journal of Law, Medicine & Ethics 42 (1): 19–27. doi:https://doi.org/10.1111/jlme.12115.
- Bourret, Pascale. 2005. “BRCA Patients and Clinical Collectives: New Configurations of Action in Cancer Genetics Practices.” Social Studies of Science 35 (1): 41–68. doi:https://doi.org/10.1177/0306312705048716.
- Bowker, Geoffrey C., and Susan Leigh Star. 1999. Sorting Things out: Classification and Its Consequences. Inside Technology. Cambridge, MA: MIT Press.
- Bröer, Christian, and Broos Besseling. 2017. “Sadness or Depression: Making Sense of Low Mood and the Medicalization of Everyday Life.” Social Science & Medicine 183: 28–36. doi:https://doi.org/10.1016/j.socscimed.2017.04.025.
- Brookes-Howell, Lucy C. 2006. “Living without Labels: The Interactional Management of Diagnostic Uncertainty in the Genetic Counselling Clinic.” Social Science & Medicine 63 (12): 3080–3091. doi:https://doi.org/10.1016/j.socscimed.2006.08.008.
- Brown, Phil. 1990. “The Name Game: Toward a Sociology of Diagnosis.” The Journal of Mind and Behaviour 11 (3-4): 385 [139]–406 [160].
- Brown, Phil. 1995. “Naming and Framing: the Social Construction of Diagnosis and Illness.” Journal of Health and Social Behavior Health Module): 34–52.
- Buetow, Stephen. 2011. “The Virtue of Uncertainty in Health Care: Virtue of Uncertainty.” Journal of Evaluation in Clinical Practice 17 (5): 873–876. doi:https://doi.org/10.1111/j.1365-2753.2011.01718.x.
- Chakravarti, A. 2011. “Genomic Contributions to Mendelian Disease.” Genome Research 21 (5): 643–644. doi:https://doi.org/10.1101/gr.123554.111.
- Chisholm, Caitlin, Hussein Daoud, Mahdi Ghani, Gabrielle Mettler, Jean McGowan-Jordan, Liz Sinclair-Bourque, Amanda Smith, and Olga Jarinova. 2018. “Reinterpretation of Sequence Variants: One Diagnostic Laboratory’s Experience, and the Need for Standard Guidelines.” Genetics in Medicine 20 (3): 365–368. doi:https://doi.org/10.1038/gim.2017.191.
- Clarke, Adele E., Janet K. Shim, Sara Shostak, and Alondra Nelson. 2009. “Biomedicalising Genetic Health, Diseases and Identities.” In Handbook of Genetics and Society: Mapping the New Genomic Era, edited by Paul Atkinson, Peter Glasner, and Margaret Lock, 21–41. Milton Park: Routledge.
- Conrad, Peter, and Kristin K. Barker. 2010. “The Social Construction of Illness: Key Insights and Policy Implications.” Journal of Health and Social Behavior 51 (1_suppl): S67–S79. doi:https://doi.org/10.1177/0022146510383495.
- Danforth, Scot, and Virginia Navarro. 2001. “Hyper Talk: Sampling the Social Construction of ADHD in Everyday Language.” Anthropology and Education Quarterly 32 (2): 167–190. doi:https://doi.org/10.1525/aeq.2001.32.2.167.
- Dar-Nimrod, Ilan, and Steven J. Heine. 2011. “Genetic Essentialism: On the Deceptive Determinism of DNA.” Psychological Bulletin 137 (5): 800–818. doi:https://doi.org/10.1037/a0021860.
- Davis, Fred. 1960. “Uncertainty in Medical Prognosis Clinical and Functional.” American Journal of Sociology 66 (1): 41–47. doi:https://doi.org/10.1086/222821.
- Dove, Edward S., Vicky Chico, Michael Fay, Graeme Laurie, Anneke M. Lucassen, and Emily Postan. 2019. “Familial Genetic Risks: How Can We Better Navigate Patient Confidentiality and Appropriate Risk Disclosure to Relatives?” Journal of Medical Ethics 45 (8): 504–507. doi:https://doi.org/10.1136/medethics-2018-105229.
- Featherstone, Katie, Joanna Latimer, Paul Atkinson, Daniella T. Pilz, and Angus Clarke. 2005. “Dysmorphology and the Spectacle of the Clinic.” Sociology of Health and Illness 27 (5): 551–574. doi:https://doi.org/10.1111/j.1467-9566.2005.00456.x.
- Fox, Renee C. 1957. “Training for Uncertainty.” In The Student Physician, edited by R. K. Merton, G. G. Reader, and P. Kendall, 207–241. Cambridge, MA: Harvard University Press.
- Fox, Renee C. 1980. “The Evolution of Medical Uncertainty.” Milbank Memorial Fund Quarterly 58: 1–49.
- Fox, Renee C. 2000. “Medical Uncertainty Revisited.” In Handbook of Social Studies in Health and Medicine, edited by G. L. Albrecht, R. Fitzpatrick, and S. C. Scrimshaw, 409–425. London: SAGE Publications.
- Gibbon, Sahra, and Carlos Novas, eds. 2008. Biosocialities, Genetics and the Social Sciences: Making Biologies and Identities. London: Routledge.
- Glaser, Barney G., and Anselm L. Strauss. 1965. Awareness of Dying. Observations. Chicago, IL: Aldine Pub. Co.
- Goldstein Jutel, Annemarie. 2019. Diagnosis: Truth and Tales. Toronto: University Of Toronto Press.
- Gordon, G. H., S. K. Joos, and J. Byme. 2000. “Physician Expressions of Uncertainty During Patient Encounters.” Patient Education and Counseling 40 (1): 59–65.
- Green, Sara, Annamaria Carusi, and Klaus Hoeyer. 2019. “Plastic Diagnostics: The Remaking of Disease and Evidence in Personalized Medicine.” Social Science & Medicine, 112318. doi:https://doi.org/10.1016/j.socscimed.2019.05.023.
- Han, Paul K.J., Kendall L. Umstead, Barbara A. Bernhardt, Robert C. Green, Steven Joffe, Barbara Koenig, Ian Krantz, Leo B. Waterston, Leslie G. Biesecker, and Barbara B. Biesecker. 2017. “A Taxonomy of Medical Uncertainties in Clinical Genome Sequencing.” Genetics in Medicine 19 (8): 918–925. doi:https://doi.org/10.1038/gim.2016.212.
- Hanquet, Germaine, Irm Vinck, and Nancy Thiry. 2018. “The Use of Whole Genome Sequencing in Clinical Practice: Challenges and Organisational Considerations for Belgium.” 300. KCE. Federaal Kenniscentrum voor de Gezondheidszorg.
- Hollin, Gregory. 2017. “Autistic Heterogeneity: Linking Uncertainties and Indeterminacies.” Science as Culture 26 (2): 209–231. doi:https://doi.org/10.1080/09505431.2016.1238886.
- Horton, Rachel H., and Anneke M. Lucassen. 2019. “Recent Developments in Genetic/Genomic Medicine.” Clinical Science 133 (5): 697–708. doi:https://doi.org/10.1042/CS20180436.
- Howard, Heidi Carmen, and Erik Iwarsson. 2018. “Mapping Uncertainty in Genomics.” Journal of Risk Research 21 (2): 117–128. doi:https://doi.org/10.1080/13669877.2016.1215344.
- Hunter, David J. 2016. “Uncertainty in the Era of Precision Medicine.” New England Journal of Medicine 375 (8): 711–713. doi:https://doi.org/10.1056/NEJMp1608282.
- Jamal, Leila, Jill O. Robinson, Kurt D. Christensen, Jennifer Blumenthal-Barby, Melody J. Slashinski, Denise Lautenbach Perry, Jason L. Vassy, Julia Wycliff, Robert C. Green, and Amy L. McGuire. 2017. “When Bins Blur: Patient Perspectives on Categories of Results from Clinical Whole Genome Sequencing.” AJOB Empirical Bioethics 8 (2): 82–88. doi:https://doi.org/10.1080/23294515.2017.1287786.
- Joyce, Kelly, and Melanie Jeske. 2020. “Using Autoimmune Strategically: Diagnostic Lumping, Splitting, and the Experience of Illness.” Social Science & Medicine 246: 112785. doi:https://doi.org/10.1016/j.socscimed.2020.112785.
- Jutel, Annemarie. 2009. “Sociology of Diagnosis: A Preliminary Review.” Sociology of Health & Illness 31 (2): 278–299. doi:https://doi.org/10.1111/j.1467-9566.2008.01152.x.
- Jutel, Annemarie. 2011. “Classification, Disease, and Diagnosis.” Perspectives in Biology and Medicine 54 (2): 189–205. doi:https://doi.org/10.1353/pbm.2011.0015.
- Jutel, Annemarie. 2015. “Beyond the Sociology of Diagnosis: Beyond the Sociology of Diagnosis.” Sociology Compass 9 (9): 841–852. doi:https://doi.org/10.1111/soc4.12296.
- Jutel, Annemarie, and Sarah Nettleton. 2011. “Towards a Sociology of Diagnosis: Reflections and Opportunities.” Social Science & Medicine 73 (6): 793–800. doi:https://doi.org/10.1016/j.socscimed.2011.07.014.
- Kerr, Anne, Julia Swallow, Choon Key Chekar, and Sarah Cunningham-Burley. 2019. “Genomic Research and the Cancer Clinic: Uncertainty and Expectations in Professional Accounts.” New Genetics and Society 38 (2): 222–239. doi:https://doi.org/10.1080/14636778.2019.1586525.
- Kim, Young-Eun, Chang-Seok Ki, and Mi-Ae Jang. 2019. “Challenges and Considerations in Sequence Variant Interpretation for Mendelian Disorders.” Annals of Laboratory Medicine 39 (5): 421–429. doi:https://doi.org/10.3343/alm.2019.39.5.421.
- Knoppers, Bartha Maria, Adrian Thorogood, and Ma’n H. Zawati. 2019. “Letter: Relearning the 3 R’s? Reinterpretation, Recontact, and Return of Genetic Variants.” Genetics in Medicine 21 (10): 2401–2402. doi:https://doi.org/10.1038/s41436-019-0494-1.
- Lane, Rhiannon. 2020. “Expanding Boundaries in Psychiatry: Uncertainty in the Context of Diagnosis-Seeking and Negotiation.” Sociology of Health & Illness 42: 69–83. doi:https://doi.org/10.1111/1467-9566.13044.
- Latimer, Joanna. 2013. The Gene, the Clinic, and the Family: Diagnosing Dysmorphology, Reviving Medical Dominance. Milton Park: Routledge.
- Latimer, Joanna, Katie Featherstone, Paul Atkinson, Angus Clarke, Daniela T. Pilz, and Alison Shaw. 2006. “Rebirthing the Clinic: The Interaction of Clinical Judgment and Genetic Technology in the Production of Medical Science.” Science, Technology, & Human Values 31 (5): 599–630. doi:https://doi.org/10.1177/0162243906289613.
- Light, Donald. 1979. “Uncertainty and Control in Professional Training.” Journal of Health and Social Behavior 20 (4): 310. doi:https://doi.org/10.2307/2955407.
- Malek, Janet, Stacey Pereira, Jill O. Robinson, Amanda M. Gutierrez, Melody J. Slashinski, D. Williams Parsons, Sharon E. Plon, and Amy L. McGuire. 2019. “Responsibility, Culpability, and Parental Views on Genomic Testing for Seriously Ill Children.” Genetics in Medicine 21 (12): 2791–2797. doi:https://doi.org/10.1038/s41436-019-0570-6.
- Malek, Janet, Melody J. Slashinski, Jill O. Robinson, Amanda M. Gutierrez, D. Williams Parsons, Sharon E. Plon, Laurence B. McCullough, and Amy L. McGuire. 2017. “Parental Perspectives on Whole-Exome Sequencing in Pediatric Cancer: A Typology of Perceived Utility.” JCO Precision Oncology, no. 1: 1–10. doi:https://doi.org/10.1200/PO.17.00010.
- Mattick, John S, Marcel Dinger, Nicole Schonrock, and Mark Cowley. 2018. “Whole Genome Sequencing Provides Better Diagnostic Yield and Future Value Than Whole Exome Sequencing.” Medical Journal of Australia 209 (5): 197–199. doi:https://doi.org/10.5694/mja17.01176.
- McGoey, Linsey. 2009. “Pharmaceutical Controversies and the Performative Value of Uncertainty.” Science as Culture 18 (2): 151–164. doi:https://doi.org/10.1080/09505430902885474.
- Mighton, Chloe, George S. Charames, Marina Wang, Kathleen-Rose Zakoor, Andrew Wong, Salma Shickh, Nicholas Watkins, Matthew S. Lebo, Yvonne Bombard, and Jordan Lerner-Ellis. 2019. “Variant Classification Changes Over Time in BRCA1 and BRCA2.” Genetics in Medicine 21 (10): 2248–2254. doi:https://doi.org/10.1038/s41436-019-0493-2.
- Mol, Annemarie. 2002. The Body Multiple: Ontology in Medical Practice. Durham, NC: Duke University Press.
- Moreira, Tiago, Carl May, and John Bond. 2009. “Regulatory Objectivity in Action: Mild Cognitive Impairment and the Collective Production of Uncertainty.” Social Studies of Science 39 (5): 665–690. doi:https://doi.org/10.1177/0306312709103481.
- Navon, Daniel. 2019. Mobilizing Mutations: Human Genetics in the Age of Patient Advocacy. Chicago, IL: The University of Chicago Press.
- Nettleton, Sarah. 2006. “‘I Just Want Permission to Be Ill’: Towards a Sociology of Medically Unexplained Symptoms.” Social Science & Medicine 62 (5): 1167–1178. doi:https://doi.org/10.1016/j.socscimed.2005.07.030.
- Newson, Ainsley J., Samantha J. Leonard, Alison Hall, and Clara L. Gaff. 2016. “Known Unknowns: Building an Ethics of Uncertainty into Genomic Medicine.” BMC Medical Genomics 9 (1): 57. doi:https://doi.org/10.1186/s12920-016-0219-0.
- Parsons, Talcott. 1951. “Illness and the Role of the Physician: A Sociological Perspective.” American Journal of Orthopsychiatry 21 (3): 452–460. doi:https://doi.org/10.1111/j.1939-0025.1951.tb00003.x.
- Pilnick, Alison, and Olga Zayts. 2014. “‘It’s Just a Likelihood’: Uncertainty as Topic and Resource in Conveying ‘Positive’ Results in an Antenatal Screening Clinic: Uncertainty as Topic and Resource.” Symbolic Interaction 37 (2): 187–208. doi:https://doi.org/10.1002/symb.99.
- Porter, Theodore M. 1995. Trust in Numbers: The Pursuit of Objectivity in Science and Public Life. Princeton, NJ: Princeton University Press.
- Quinlan-Jones, Elizabeth, Sarah C. Hillman, Mark D. Kilby, and Sheila M. Greenfield. 2017. “Parental Experiences of Prenatal Whole Exome Sequencing (WES) in Cases of Ultrasound Diagnosed Fetal Structural Anomaly.” Prenatal Diagnosis 37 (12): 1225–1231. doi:https://doi.org/10.1002/pd.5172.
- Rabeharisoa, Vololona, and Pascale Bourret. 2009. “Staging and Weighting Evidence in Biomedicine: Comparing Clinical Practices in Cancer Genetics and Psychiatric Genetics.” Social Studies of Science 39 (5): 691–715. doi:https://doi.org/10.1177/0306312709103501.
- Rabinow, Paul. 1996. Essays on the Anthropology of Reason. Princeton Studies in Culture/Power/History. Princeton, NJ: Princeton University Press.
- Reinsch, Stefan. 2020. “Decision-Making about Non-Invasive Prenatal Testing: Women’s Moral Reasoning in the Absence of a Risk of Miscarriage in Germany,” 18.
- Robinson, Jill O., Julia Wynn, Barbara Biesecker, Leslie G. Biesecker, Barbara Bernhardt, Kyle B. Brothers, Wendy K. Chung, et al. 2019. “Psychological Outcomes Related to Exome and Genome Sequencing Result Disclosure: A Meta-Analysis of Seven Clinical Sequencing Exploratory Research (CSER) Consortium Studies.” Genetics in Medicine 21 (12): 2781–2790. doi:https://doi.org/10.1038/s41436-019-0565-3.
- Rosell, Allyn McConkie, Loren D. M. Pena, Kelly Schoch, Rebecca Spillmann, Jennifer Sullivan, Stephen R. Hooper, Yong-Hui Jiang, Nicolas Mathey-Andrews, David B. Goldstein, and Vandana Shashi. 2016. “Not the End of the Odyssey: Parental Perceptions of Whole Exome Sequencing (WES) in Pediatric Undiagnosed Disorders.” Journal of Genetic Counseling 25 (5): 1019–1031. doi:https://doi.org/10.1007/s10897-016-9933-1.
- Sarangi, Srikant. 2002. “The Language of Likelihood in Genetic-Counseling Discourse.” Journal of Language and Social Psychology 21 (1): 7–31. doi:https://doi.org/10.1177/0261927X02021001002.
- Sarangi, Srikant, and Angus Clarke. 2002. “Constructing an Account by Contrast in Counselling for Childhood Genetic Testing.” Social Science & Medicine 54 (2): 295–308. doi:https://doi.org/10.1016/S0277-9536(01)00029-6.
- Sawyer, S. L., T. Hartley, D. A. Dyment, C. L. Beaulieu, J. Schwartzentruber, A. Smith, H. M. Bedford, et al. 2016. “Utility of Whole-Exome Sequencing for Those Near the End of the Diagnostic Odyssey: Time to Address Gaps in Care: Whole-Exome Sequencing for Rare Disease Diagnosis.” Clinical Genetics 89 (3): 275–284. doi:https://doi.org/10.1111/cge.12654.
- Shabani, Mahsa, Louise Bezuidenhout, and Pascal Borry. 2014. “Attitudes of Research Participants and the General Public Towards Genomic Data Sharing: A Systematic Literature Review.” Expert Review of Molecular Diagnostics 14 (8): 1053–1065. doi:https://doi.org/10.1586/14737159.2014.961917.
- Shashi, V., A. McConkie-Rosell, K. Schoch, V. Kasturi, C. Rehder, Y. H. Jiang, D. B. Goldstein, and M. T. McDonald. 2016. “Practical Considerations in the Clinical Application of Whole-Exome Sequencing.” Clinical Genetics 89 (2): 173–181. doi:https://doi.org/10.1111/cge.12569.
- Shaw, Alison, Joanna Latimer, Paul Atkinson, and Katie Featherstone. 2003. “Surveying ‘Slides’: Clinical Perception and Clinical Judgment in the Construction of a Genetic Diagnosis.” New Genetics and Society 22 (1): 3–19. doi:https://doi.org/10.1080/1463677032000069682.
- Simpkin, Arabella L., and Richard M. Schwartzstein. 2016. “Tolerating Uncertainty — The Next Medical Revolution?” New England Journal of Medicine 375 (18): 1713–1715. doi:https://doi.org/10.1056/NEJMp1606402.
- Skinner, Debra, Kelly A. Raspberry, and Martha King. 2016. “The Nuanced Negative: Meanings of a Negative Diagnostic Result in Clinical Exome Sequencing.” Sociology of Health & Illness 38 (8): 1303–1317. doi:https://doi.org/10.1111/1467-9566.12460.
- Skinner, Debra, Myra I. Roche, Karen E. Weck, Kelly A Raspberry, A. Katherine, M. Foreman, Natasha T. Strande, Jonathan S. Berg, James P. Evans, and Gail E. Henderson. 2018. “‘Possibly Positive or Certainly Uncertain?’: Participants’ Responses to Uncertain Diagnostic Results from Exome Sequencing.” Genetics in Medicine 20 (3): 313–319. doi:https://doi.org/10.1038/gim.2017.135.
- Star, Susan L. 1985. “Scientific Work and Uncertainty.” Social Studies of Science 15 (3): 391–427. doi:https://doi.org/10.1177/030631285015003001.
- Stivers, Tanya, and Stefan Timmermans. 2016. “Negotiating the Diagnostic Uncertainty of Genomic Test Results.” Social Psychology Quarterly 79 (3): 199–221. doi:https://doi.org/10.1177/0190272516658770.
- Stivers, Tanya, and Stefan Timmermans. 2017. “The Actionability of Exome Sequencing Testing Results.” Sociology of Health & Illness 39 (8): 1542–1556. doi:https://doi.org/10.1111/1467-9566.12614.
- Stockl, Andrea. 2007. “Complex Syndromes, Ambivalent Diagnosis, and Existential Uncertainty: The Case of Systemic Lupus Erythematosus (SLE).” Social Science & Medicine 65 (7): 1549–1559. doi:https://doi.org/10.1016/j.socscimed.2007.05.016.
- Tabor, Holly K., Jacquie Stock, Tracy Brazg, Margaret J. McMillin, Karin M. Dent, Joon-Ho Yu, Jay Shendure, and Michael J. Bamshad. 2012. “Informed Consent for Whole Genome Sequencing: A Qualitative Analysis of Participant Expectations and Perceptions of Risks, Benefits, and Harms.” American Journal of Medical Genetics Part A 158A (6): 1310–1319. doi:https://doi.org/10.1002/ajmg.a.35328.
- Timmermans, Stefan. 2015. “Trust in Standards: Transitioning Clinical Exome Sequencing from Bench to Bedside.” Social Studies of Science 45 (1): 77–99. doi:https://doi.org/10.1177/0306312714559323.
- Timmermans, Stefan, and Alison Angell. 2001. “Evidence-Based Medicine, Clinical Uncertainty, and Learning to Doctor.” Journal of Health and Social Behavior 42 (4): 342. doi:https://doi.org/10.2307/3090183.
- Timmermans, Stefan, and Marc Berg. 2010. The Gold Standard: The Challenge of Evidence-Based Medicine. Philadelphia, PA: Temple University Press.
- Timmermans, Stefan, and Tanya Stivers. 2018. “The Social Utility of Clinical Exome Sequencing.” Patient Education and Counseling 101 (2): 221–226. doi:https://doi.org/10.1016/j.pec.2017.08.010.
- Timmermans, Stefan, Caroline Tietbohl, and Eleni Skaperdas. 2017. “Narrating Uncertainty: Variants of Uncertain Significance (VUS) in Clinical Exome Sequencing.” BioSocieties 12 (3): 439–458. doi:https://doi.org/10.1057/s41292-016-0020-5.
- Turner, Scott A., Smita K. Rao, R. Hayes Morgan, Cindy L. Vnencak-Jones, and Georgia L. Wiesner. 2019. “The Impact of Variant Classification on the Clinical Management of Hereditary Cancer Syndromes.” Genetics in Medicine 21 (2): 426–430. doi:https://doi.org/10.1038/s41436-018-0063-z.
- Vears, Danya F., Karine Sénécal, and Pascal Borry. 2017. “Reporting Practices for Variants of Uncertain Significance from Next Generation Sequencing Technologies.” European Journal of Medical Genetics 60 (10): 553–558. doi:https://doi.org/10.1016/j.ejmg.2017.07.016.
- Vears, Danya F., Karine Sénécal, and Pascal Borry. 2019. “Genetic Health Professionals' Experiences Returning Results from Diagnostic Genomic Sequencing to Patients.” Journal of Genetic Counseling 29 (5): 807–815. doi:https://doi.org/10.1002/jgc4.v29.5.
- Walser, Sarah A., Allison Werner-Lin, Rebecca Mueller, Victoria A. Miller, Sawona Biswas, and Barbara A. Bernhardt. 2017. “How Do Providers Discuss the Results of Pediatric Exome Sequencing with Families?” Personalized Medicine 14 (5): 409–422. doi:https://doi.org/10.2217/pme-2017-0015.
- Wauters, Annet, and Ine Van Hoyweghen. 2016. “Global Trends on Fears and Concerns of Genetic Discrimination: A Systematic Literature Review.” Journal of Human Genetics 61 (4): 275–282. doi:https://doi.org/10.1038/jhg.2015.151.
- Weiner, Kate, Paul Martin, Martin Richards, and Richard Tutton. 2017. “Have We Seen the Geneticisation of Society? Expectations and Evidence.” Sociology of Health & Illness 39 (7): 989–1004. doi:https://doi.org/10.1111/1467-9566.12551.
- Whitmarsh, Ian, Arlene M. Davis, Debra Skinner, and Donald B. Bailey. 2007. “A Place for Genetic Uncertainty: Parents Valuing an Unknown in the Meaning of Disease.” Social Science & Medicine 65 (6): 1082–1093. doi:https://doi.org/10.1016/j.socscimed.2007.04.034.
- Wood, Fiona, Lindsay Prior, and Jonathon Gray. 2003. “Translations of Risk: Decision Making in a Cancer Genetics Service.” Health, Risk & Society 5 (2): 185–198. doi:https://doi.org/10.1080/1369857031000123957.
- Yong, Ed. 2013. “‘We Gained Hope.’ The Story of Lilly Grossman’s Genome.” National Geographic: Not Exactly Rocket Science (blog). March 11, 2013. https://www.nationalgeographic.com/science/phenomena/2013/03/11/we-gained-hope-the-story-of-lilly-grossmans-genome/.
- Yu, Joon-Ho, Tanya M. Harrell, Seema M. Jamal, Holly K. Tabor, and Michael J. Bamshad. 2014. “Attitudes of Genetics Professionals Toward the Return of Incidental Results from Exome and Whole-Genome Sequencing.” The American Journal of Human Genetics 95 (1): 77–84. doi:https://doi.org/10.1016/j.ajhg.2014.06.004.